Research Luncheon

Presented by:

Promise, Research, Cures Luncheon
Thursday, June 6
Project 658 (3646 Central Avenue)
Doors open at 11:00 a.m., programming runs from 11:30-1:30

You’re invited to join Susan G. Komen Charlotte to learn about the latest updates in breast cancer research and the impact our local funds have in finding the cures for breast cancer. This event is a unique opportunity for Komen Charlotte partners, donors and advocates to learn about Susan G. Komen’spromiseto end breast cancer forever through cutting-edge breast cancer research, and how your financial contributions are being used in scientific labs to find thecures. For 33 years, Susan G. Komen research has fueled our knowledge of breast cancer – and we want to educate others on the cutting edge research that happens everyday.

We’re honored to host Komen Scholars Dr. Donald McDonnell, Chair of the Department of Pharmacology and Cancer Biology at Duke University, and Dr. Amelie Ramirez,  Director and Professor, Institute for Health Promotion Research, UT Health San Antonio, as they share their findings and how Susan G. Komen has fueled their research efforts.

Purchase Tickets
Ticket Options:

Individual Ticket: $40
Ribbon Table Sponsor: $300 for table of eight seats

Each ticket includes plated lunch and presentation by Komen Scholars. Ribbon Table Sponsorship includes individual or company name listed on website, event signage and lunch program, as well as table sign.


Amelie G. Ramirez, DrPH, an internationally recognized cancer and chronic disease health disparities researcher, is interim chair and professor of epidemiology and biostatistics at UT Health San Antonio, where she also is founding director of the Institute for Health Promotion Research and associate director of cancer prevention and health disparities at the UT Health San Antonio Cancer Center.

Over 30 years, she has led behavioral and communications research that reduced cancer and chronic disease, increased screening rates and clinical trial accrual, and improved healthyeating and physical activity among U.S. Latinos. Dr. Ramirez directs the Salud America! multimedia program to empower healthy changes to promote healthy weight among Latino children (salud-america.org and @SaludAmerica on social media). She also uses innovative technology—such as text messaging, social media, and mobile apps—to reach Latinos in real-time with behavior-change messages and interventions on smoking cessation and other topics. Her recognitions include the 2014 Making a Difference Award from Latinas Contra Cancer, the 2011 White House “Champion of Change” and the 2007 election to the Institute of Medicine of the National Academies.

 

 


Donald P. McDonnell, Ph.D., is the Glaxo-Wellcome Professor of Molecular Cancer Biology and Chairman of the Department of Pharmacology and Cancer Biology at Duke University School of Medicine. In addition, he serves as Co-Director of the Women’s Cancer Program within the Duke Cancer Institute.

With a career spanning industry and academia, Dr. McDonnell’s research has focused on defining the mechanisms of action of estrogens and its cognate receptors in breast cancer and the exploitation of this information to develop new endocrine therapies. He has a specific interest in developing new therapeutic interventions to treat cancers that have become resistant to standard of care endocrine therapies, work that resulted in the discovery by his group of the first oral selective estrogen receptor downregulator. Recently, his group has determined that metabolites of cholesterol, elevated in patients with dyslipidemia, can function as bona fide estrogens establishing a biochemical link between high cholesterol/obesity and breast cancer pathology. Dr. McDonnell’s Komen-funded research aims are directed towards the development of approaches to interfere with the activity of LYPD3 (Ly6/PLAUR domain-containing protein 3) and AGR2 (Anterior Gradient 2); two components of a novel signaling pathway that his team has shown to be important in the pathobiology of endocrine therapy-resistant breast cancer.

 

 


Sponsored by:

If your company is interested in sponsoring this event, please contact Jen Wolf at j.wolf@komencharlotte.org.

 

 

About Project 658

Project 658 is a local nonprofit organization dedicated to providing an integrated path for holistic life change. Currently, 1 in 6 Charlotteans live below the poverty line and 25% of all children under 18 live under the poverty line. 165,000 residents are food insecure (not knowing where their next meal will come from).

All proceeds from event rentals directly impact their ministry projects providing services to at-risk families in Charlotte, moving them toward sustainability. Every catering order is part of their 1:1 feeding program. Each meal purchased sponsors a meal in the Project 658 feeding program; a meal purchased is a meal provided.

 

Go to Top